Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Semaglutide

PLASTIC

Novo Nordisk · Phase 3 · Not yet recruiting · Enrollment 120

NCT07021937

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Pubertal Adolescent - Continuous Treatmentn/rn/rn/rn/r
Pubertal Adolescent - Early Treatment Cessationn/rn/rn/rn/r
Post-Pubertal Adolescent - Continuous Treatmentn/rn/rn/rn/r
Post-Pubertal Adolescent - Early Treatment Cessationn/rn/rn/rn/r
Adult - Continuous Treatmentn/rn/rn/rn/r
Adult - Early Treatment Cessationn/rn/rn/rn/r

Not shown

  • Pubertal Adolescent - Continuous Treatment: endpoint not reported
  • Pubertal Adolescent - Early Treatment Cessation: endpoint not reported
  • Post-Pubertal Adolescent - Continuous Treatment: endpoint not reported
  • Post-Pubertal Adolescent - Early Treatment Cessation: endpoint not reported
  • Adult - Continuous Treatment: endpoint not reported
  • Adult - Early Treatment Cessation: endpoint not reported